THESEUS PHARMACEUTICALS, INC. Stock Split Ratio
THESEUS PHARMACEUTICALS, INC. had Stock Split Ratio of 132.29% as of 2021-09-27, per its 10-K filed 2023-03-09.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2023-03-09
- 2021-09-27: Stockholders' Equity Note, Stock Split, Conversion Ratio 132.29%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2021-09-27 | 132.29% 10-K · filed 2023-03-09 |